{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:19Z","timestamp":1707524959252},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,29]]},"DOI":"10.7759\/cureus.36874","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T20:02:49Z","timestamp":1680120169000},"source":"Crossref","is-referenced-by-count":0,"title":["Dilated Cardiomyopathy: Beware of Diet Drugs Slimming the Heart"],"prefix":"10.7759","author":[{"given":"Pradnya Brijmohan","family":"Bhattad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramukh","family":"Arun Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahati","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akil A","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay K","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen W","family":"Filiberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley TM","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, et al.. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021, 143:e984-e1010. 10.1161\/CIR.0000000000000973","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000145","article-title":"Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity","volume":"32","author":"Jordan J","year":"2014","unstructured":"Jordan J, Astrup A, Engeli S, Narkiewicz K, Day WW, Finer N. Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity. J Hypertens. 2014, 32:1178-88. 10.1097\/HJH.0000000000000145","journal-title":"J Hypertens"},{"key":"ref3","article-title":"","author":"Mahmaljy H","year":"2023","unstructured":"Mahmaljy H, Yelamanchili VS, Singhal M. Dilated Cardiomyopathy. StatPearls Publishing, Treasure Island; 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/28722940\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2018.1497172","article-title":"Mechanisms of toxic cardiomyopathy","volume":"57","author":"Hantson P","year":"2019","unstructured":"Hantson P. Mechanisms of toxic cardiomyopathy. Clin Toxicol (Phila). 2019, 57:1-9. 10.1080\/15563650.2018.1497172","journal-title":"Clin Toxicol (Phila)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S31443","article-title":"Phentermine and topiramate for the management of obesity: a review","volume":"7","author":"Cosentino G","year":"2013","unstructured":"Cosentino G, Conrad AO, Uwaifo GI. Phentermine and topiramate for the management of obesity: a review. Drug Des Devel Ther. 2013, 7:267-78. 10.2147\/DDDT.S31443","journal-title":"Drug Des Devel Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629040-00001","article-title":"Safety of drug therapies used for weight loss and treatment of obesity","volume":"29","author":"Ioannides-Demos LL","year":"2006","unstructured":"Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf. 2006, 29:277-302. 10.2165\/00002018-200629040-00001","journal-title":"Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12328","article-title":"Update on obesity pharmacotherapy","volume":"1311","author":"Bray GA","year":"2014","unstructured":"Bray GA, Ryan DH. Update on obesity pharmacotherapy. Ann N Y Acad Sci. 2014, 1311:1-13. 10.1111\/nyas.12328","journal-title":"Ann N Y Acad Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1970.tb08035.x","article-title":"A case of drug-induced (?) pulmonary hypertension","volume":"188","author":"Malmquist J","year":"1970","unstructured":"Malmquist J, Trell E, Torp A, Lindstr\u00f6m C. A case of drug-induced (?) pulmonary hypertension. Acta Med Scand. 1970, 188:265-72. 10.1111\/j.0954-6820.1970.tb08035.x","journal-title":"Acta Med Scand"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1999.tb00414.x","article-title":"Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine","volume":"7","author":"Ryan DH","year":"1999","unstructured":"Ryan DH, Bray GA, Helmcke F, et al.. Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine. Obes Res. 1999, 7:313-22. 10.1002\/j.1550-8528.1999.tb00414.x","journal-title":"Obes Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708283370911","article-title":"Further cases of valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Graham DJ","year":"1997","unstructured":"Graham DJ, Green L. Further cases of valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997, 337:635. 10.1056\/NEJM199708283370911","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.1.102","article-title":"Asymptomatic mitral and aortic valve disease is seen in half of the patients taking 'phen-fen'","volume":"158","author":"Griffen L","year":"1998","unstructured":"Griffen L, Anchors M. Asymptomatic mitral and aortic valve disease is seen in half of the patients taking 'phen-fen'. Arch Intern Med. 1998, 158:102. 10.1001\/archinte.158.1.102","journal-title":"Arch Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199809103391112","article-title":"Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment","volume":"339","author":"Cannistra LB","year":"1998","unstructured":"Cannistra LB, Cannistra AJ. Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment. N Engl J Med. 1998, 339:771. 10.1056\/nejm199809103391112","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804303381816","article-title":"Endocardial fibrosis associated with fenfluramine-phentermine","volume":"338","author":"Fowles RE","year":"1998","unstructured":"Fowles RE, Cloward TV, Yowell RL. Endocardial fibrosis associated with fenfluramine-phentermine. N Engl J Med. 1998, 338:1316. 10.1056\/NEJM199804303381816","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.49.2.632","article-title":"Cerebral hemorrhage in a patient taking fenfluramine and phentermine for obesity","volume":"49","author":"Wen PY","year":"1997","unstructured":"Wen PY, Feske SK, Teoh SK, Stieg PE. Cerebral hemorrhage in a patient taking fenfluramine and phentermine for obesity. Neurology. 1997, 49:632-3. 10.1212\/wnl.49.2.632","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.24.2.310","article-title":"Possible association of ischemic stroke with phentermine","volume":"24","author":"Kokkinos J","year":"1993","unstructured":"Kokkinos J, Levine SR. Possible association of ischemic stroke with phentermine. Stroke. 1993, 24:310-3. 10.1161\/01.str.24.2.310","journal-title":"Stroke"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.12890\/2020_001595","article-title":"Takotsubo cardiomyopathy due to combined use of phentermine and lisdexamfetamine","volume":"7","author":"Burleigh T","year":"2020","unstructured":"Burleigh T, Khandalavala B. Takotsubo cardiomyopathy due to combined use of phentermine and lisdexamfetamine. Eur J Case Rep Intern Med. 2020, 7:001595. 10.12890\/2020_001595","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.01.045","article-title":"Inverted takotsubo cardiomyopathy in a patient with essential thrombocythemia exposed to anagrelide and phentermine","volume":"160","author":"Dziewierz A","year":"2012","unstructured":"Dziewierz A, Olszanecka A, Wili\u0144ski J, Rakowski T, Kleczy\u0144ski P, Dubiel JS, Dudek D. Inverted takotsubo cardiomyopathy in a patient with essential thrombocythemia exposed to anagrelide and phentermine. Int J Cardiol. 2012, 160:e31-2. 10.1016\/j.ijcard.2012.01.045","journal-title":"Int J Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2007.10.040","article-title":"Cardiac arrest in the setting of diet pill consumption","volume":"26","author":"Makaryus JN","year":"2008","unstructured":"Makaryus JN, Makaryus AN. Cardiac arrest in the setting of diet pill consumption. Am J Emerg Med. 2008, 26:732.e1-3. 10.1016\/j.ajem.2007.10.040","journal-title":"Am J Emerg Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2006.02.004","article-title":"Weight-reducing regimen associated with polymorphic ventricular tachycardia","volume":"24","author":"Hung YM","year":"2006","unstructured":"Hung YM, Chang JC. Weight-reducing regimen associated with polymorphic ventricular tachycardia. Am J Emerg Med. 2006, 24:714-6. 10.1016\/j.ajem.2006.02.004","journal-title":"Am J Emerg Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.94.9.2216","article-title":"Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction","volume":"94","author":"Weir EK","year":"1996","unstructured":"Weir EK, Reeve HL, Huang JM, Michelakis E, Nelson DP, Hampl V, Archer SL. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circulation. 1996, 94:2216-20. 10.1161\/01.cir.94.9.2216","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2021.1901476","article-title":"Supraventricular tachycardia with the use of phentermine: case report and review of literature","volume":"133","author":"Kumar S","year":"2021","unstructured":"Kumar S, Mogalapalli A, Srinivasamurthy R, Hussain ST, Mar PL. Supraventricular tachycardia with the use of phentermine: case report and review of literature. Postgrad Med. 2021, 133:454-7. 10.1080\/00325481.2021.1901476","journal-title":"Postgrad Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00000433-199606000-00014","article-title":"Cardiac muscle lesions associated with chronic administration of methamphetamine in rats","volume":"17","author":"He SY","year":"1996","unstructured":"He SY, Matoba R, Fujitani N, Sodesaki K, Onishi S. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am J Forensic Med Pathol. 1996, 17:155-62. 10.1097\/00000433-199606000-00014","journal-title":"Am J Forensic Med Pathol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-020-0544-4","article-title":"The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database","volume":"44","author":"Gorelik E","year":"2020","unstructured":"Gorelik E, Gorelik B, Masarwa R, Perlman A, Hirsh-Raccah B, Matok I. The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database. Int J Obes (Lond). 2020, 44:1021-7. 10.1038\/s41366-020-0544-4","journal-title":"Int J Obes (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/140820-dilated-cardiomyopathy-beware-of-diet-drugs-slimming-the-heart","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:29Z","timestamp":1707508769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/140820-dilated-cardiomyopathy-beware-of-diet-drugs-slimming-the-heart"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.36874","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,29]]}}}